tradingkey.logo
搜尋

Accuray Inc

ARAY
添加自選
0.260USD
+0.002+0.66%
收盤 07/01, 16:00美東報價延遲15分鐘
30.87M總市值
虧損本益比TTM

Accuray Inc

0.260
+0.002+0.66%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.66%

5天

-21.39%

1月

-33.29%

6月

-68.53%

今年開始到現在

-68.53%

1年

-80.92%

關鍵數據
0.259今開
0.267最高
2.00M成交量
虧損本益比TTM
虧損本益比動
--股利TTM
1.68%換手率
0.258昨收
0.255最低
431.84K成交額
虧損本益比靜
0.74市淨率
0.00%股息率 TTM
-9.90%ROA
2.10052週最高
0.53量比
-1.59M淨利潤
118.93M總股本
-0.3780每股盈餘TTM
1.34Beta
-101.06%ROE
0.33052週最低
4.38%振幅
23.76%毛利率
30.87M總市值
-6.30回報/風險
5.60%風險率

TradingKey Accuray Inc股票評分

單位: USD 更新時間: 2026-07-01

操作建議

Accuray Inc當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名107/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為持有。最高目標價為0.35。中期看,股價處於下降通道。近一個月,市場表現非常差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Accuray Inc評分

相關信息

行業排名
107 / 204
全市場排名
279 / 4564
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

Accuray Inc亮點

亮點風險
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
估值高估
公司最新PE估值-0.69,處於3年歷史高位
機構減倉
最新機構持股85.92M股,環比減少3.71%
ETHSX持倉
明星投資者ETHSX持倉,最新持倉2.71K股
活躍度降低
近期活躍度降低,過去20天平均換手率0.71

分析師目標

基於 2 分析師
持有
評級
0.350
目標均價
+35.76%
漲幅空間

Accuray Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Accuray Inc簡介

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
公司代碼ARAY
公司Accuray Inc
CEOLa Neve (Stephen R)
網址https://www.accuray.com/

常見問題

Accuray Inc(ARAY)的當前股價是多少?

Accuray Inc(ARAY)的當前股價是 0.26。

Accuray Inc 的股票代碼是什麼?

Accuray Inc的股票代碼是ARAY。

Accuray Inc股票的52週最高點是多少?

Accuray Inc股票的52週最高點是2.10。

Accuray Inc股票的52週最低點是多少?

Accuray Inc股票的52週最低點是0.33。

Accuray Inc的市值是多少?

Accuray Inc的市值是30.86M。

現在Accuray Inc(ARAY)的股票是買入、持有還是賣出?

根據分析師評級,Accuray Inc(ARAY)的總體評級為signal_hold,目標價格為0.35。

Accuray Inc(ARAY)股票的每股收益(EPS TTM)是多少

Accuray Inc(ARAY)股票的每股收益(EPS TTM)是-0.02。